“Ante la duda, usad Haloperidol”. ¿O no?

Ignacio Jáuregui-Lobera, Jesus M. Culebras

Resumen


-

Palabras clave


-

Texto completo:

PDF / HTML / CITATION

Referencias


Oransky I. Paul Janssen (Obituary). The Lancet 2004;363:251.

Medrano J. Boticarium. Rev Asoc EspNeuropsiq2014;34:175-194.

Girard TD, Exline MC, Carson SS, Hough CL, Rock P, Gong MN, et al. Haloperidol and Ziprasidone for treatmentof delirium in critical illness. NEnglJMed 2018;379;2506-16.

López-Muñoz F, Alamo C. The consolidation of neuroleptic therapy: Janssen, the discovery of haloperidol and its introduction into clinical practice. Brain Res Bull 2009; 79:130-41.

Latronico N. Haloperidol and delirium in the ICU: thefinger pointing to the moon. Intensive Care Med 2018;44:1346-48.

Markowitz JD, NarasimhanM. Delirium and antipsychotics:A systematic review of epidemiology and somatic treatment options. Psychiatry (Edgemont) 2008;5:29-36.

European Delirium Association y American Delirium Society. The DSM- 5 criteria, level of arousal and delirium diagnosis: inclusiveness is safer. BMC Medicine 2014;12:141.

Shen Y. · Peng K. · Zhang J. · Meng X. · Ji F. Effects of Haloperidol on Delirium in Adult Patients: A Systematic Review and Meta-Analysis. Med Princ Pract 2018;27:250–259 https://doi.org/10.1159/000488243

Bleck TP. Dopamine antagonists in ICU delirium. NEnglJMed 2018;379;2569-70.




DOI: https://doi.org/10.19230/jonnpr.3011

Número de visitas del artículo: 9

Número de descargas: 15

Número de descargas: 0

Número de descargas: 3

Enlaces refback

  • No hay ningún enlace refback.


Copyright (c) 2019 Journal of Negative and No Positive Results

Incluida in:

BASES DE DATOS Y BUSCADORES

Google Scholar Hinari J-Gate ResearchBib

CATALOGOS DE REVISTAS

Dialnet DOAJ DRJI mEDRA REDIB ROAD

INDICES DE CITAS

Citefactor isindexing MIAR

INICIATIVAS DE ACCESO ABIERTO

Dulcinea SHERPA/ROMEO

Journal of Negative and No Positive Results

Edita: Research and Science S.L.

ISSN-e: 2529-850X

Dep. Legal: Exento R.D. 635/2015

Contact:   contacto@jnnpr.com

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License

The journal does not charge fees for job submission, no fees for the publication of their articles.